Dr. Jasper Dingemanse is currently Vice President and Head Clinical Pharmacology at Actelion Pharmaceuticals Ltd, Switzerland. In this function he is responsible for the Phase I and early Phase II trials of a range of compounds covering a broad spectrum of therapeutic areas (cardiovasculars, central nervous system, infectiology, immunology, respiratory).
Previous positions included functions as Senior Director at The Medicines Company and Group Leader in Clinical Pharmacology at F. Hoffmann-La Roche. In addition, Dr. Dingemanse gained experience as Scientific Director at two CROs.
He is the author of approximately 250 peer-reviewed articles covering preclinical and clinical pharmacology studies in various fields.